These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3584485)

  • 1. Granular cells as a marker of early amiodarone hepatotoxicity: a pathological and analytical study.
    Shepherd NA; Dawson AM; Crocker PR; Levison DA
    J Clin Pathol; 1987 Apr; 40(4):418-23. PubMed ID: 3584485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amiodarone hepatotoxicity. A clinicopathologic study of five patients.
    Rigas B; Rosenfeld LE; Barwick KW; Enriquez R; Helzberg J; Batsford WP; Josephson ME; Riely CA
    Ann Intern Med; 1986 Mar; 104(3):348-51. PubMed ID: 3946978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granular cells as a marker of early amiodarone hepatotoxicity.
    Jain D; Bowlus CL; Anderson JM; Robert ME
    J Clin Gastroenterol; 2000 Oct; 31(3):241-3. PubMed ID: 11034006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amiodarone-induced hepatic phospholipidosis: a morphological alteration independent of pseudoalcoholic liver disease.
    Guigui B; Perrot S; Berry JP; Fleury-Feith J; Martin N; Métreau JM; Dhumeaux D; Zafrani ES
    Hepatology; 1988; 8(5):1063-8. PubMed ID: 3417226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electron microscopic demonstration of lysosomal inclusion bodies in lung, liver, lymph nodes, and blood leukocytes of patients with amiodarone pulmonary toxicity.
    Dake MD; Madison JM; Montgomery CK; Shellito JE; Hinchcliffe WA; Winkler ML; Bainton DF
    Am J Med; 1985 Mar; 78(3):506-12. PubMed ID: 2983550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amiodarone-associated phospholipidosis and fibrosis of the liver. Light, immunohistochemical, and electron microscopic studies.
    Poucell S; Ireton J; Valencia-Mayoral P; Downar E; Larratt L; Patterson J; Blendis L; Phillips MJ
    Gastroenterology; 1984 May; 86(5 Pt 1):926-36. PubMed ID: 6706074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous pigmentation secondary to amiodarone therapy.
    Trimble JW; Mendelson DS; Fetter BF; Ingram P; Gallagher JJ; Shelburne JD
    Arch Dermatol; 1983 Nov; 119(11):914-8. PubMed ID: 6639112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Severe hepatotoxicity caused by amiodarone: description of a case].
    Latorre G; Lucas I; Herrero JI; Sangro B; Quiroga J; Sola JJ; Díaz L; Prieto J
    Rev Med Univ Navarra; 1999; 43(2):86-91. PubMed ID: 11256009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic liver disease after low daily doses of amiodarone. Report of three cases.
    Babany G; Mallat A; Zafrani ES; Saint-Marc Girardin MF; Carcone B; Dhumeaux D
    J Hepatol; 1986; 3(2):228-32. PubMed ID: 3794303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Causality assessment of liver injury after chronic oral amiodarone intake.
    Llanos L; Moreu R; Peiró AM; Pascual S; Francés R; Such J; Horga JF; Pérez-Mateo M; Zapater P
    Pharmacoepidemiol Drug Saf; 2009 Apr; 18(4):291-300. PubMed ID: 19165760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amiodarone-induced reversible and irreversible hepatotoxicity: two case reports.
    Tsuda T; Tada H; Tanaka Y; Nishida N; Yoshida T; Sawada T; Sakata K; Hayashi K; Kawashiri MA; Oyama T; Sasaki M; Kurose N; Yamagishi M
    J Med Case Rep; 2018 Apr; 12(1):95. PubMed ID: 29653592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amiodarone-induced liver cirrhosis and parkinsonism: a case report.
    Ishida S; Sugino M; Hosokawa T; Sato T; Furutama D; Fukuda A; Kimura F; Kuwabara H; Shibayama Y; Hanafusa T
    Clin Neuropathol; 2010; 29(2):84-8. PubMed ID: 20175957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histopathologic analysis of suspected amiodarone hepatotoxicity.
    Lewis JH; Mullick F; Ishak KG; Ranard RC; Ragsdale B; Perse RM; Rusnock EJ; Wolke A; Benjamin SB; Seeff LB
    Hum Pathol; 1990 Jan; 21(1):59-67. PubMed ID: 2403975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudocyanotic pigmentation of the skin induced by amiodarone: a light and electron microscopic study.
    Delage C; Lagacé R; Huard J
    Can Med Assoc J; 1975 May; 112(10):1205-8. PubMed ID: 47784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three cases of severe acute hepatitis after parenteral administration of amiodarone: the active ingredient is not the only agent responsible for hepatotoxicity.
    Giannattasio F; Salvio A; Varriale M; Picciotto FP; Di Costanzo GG; Visconti M
    Ann Ital Med Int; 2002; 17(3):180-4. PubMed ID: 12402666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acceleration of ventricular rate by fibrillation associated with the Wolff-Parkinson-White syndrome.
    Sheinman BD; Evans T
    Br Med J (Clin Res Ed); 1982 Oct; 285(6347):999-1000. PubMed ID: 6812745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amiodarone-induced torsade de pointes in a patient with wolff-Parkinson-White syndrome.
    Badshah A; Mirza B; Janjua M; Nair R; Steinman RT; Cotant JF
    Hellenic J Cardiol; 2009; 50(3):224-6. PubMed ID: 19465366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrastructural evidence of thyroid damage in amiodarone-induced thyrotoxicosis.
    Cappiello E; Boldorini R; Tosoni A; Piraneo S; Bernasconi R; Raggi U
    J Endocrinol Invest; 1995 Dec; 18(11):862-8. PubMed ID: 8778159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acute hepatopathy caused by amiodarone. Study of a case and review of the literature].
    Capron-Chivrac D; Reix N; Quénum C; Capron JP
    Gastroenterol Clin Biol; 1985; 9(6-7):535-9. PubMed ID: 4018488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatal hepatotoxicity following oral administration of amiodarone.
    Richer M; Robert S
    Ann Pharmacother; 1995 Jun; 29(6):582-6. PubMed ID: 7663029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.